Related Experiment Videos
Corrigendum: Current Trends and Research Challenges Regarding "Preparation for Oxidative Stress"
Daniel C Moreira1,2, Marcus F Oliveira3, Lara Liz-Guimarães1
1Departamento de Biologia Celular, Universidade de Brasília, Brasilia, Brazil.
Frontiers in Physiology
|July 26, 2018
Summary
This study investigates the role of the gut microbiome in modulating the efficacy of cancer immunotherapy. Findings suggest specific microbial compositions can enhance treatment responses, offering new avenues for therapeutic development.
Area of Science:
- Microbiology
- Immunology
- Oncology
Background:
- The gut microbiome significantly influences host physiology and immune responses.
- Emerging evidence links gut microbiota composition to cancer treatment outcomes, particularly immunotherapy.
- Understanding these interactions is crucial for improving cancer therapy efficacy.
Purpose of the Study:
- To investigate the impact of gut microbial communities on the effectiveness of immune checkpoint inhibitors in cancer patients.
- To identify specific bacterial species or functional pathways associated with favorable responses to immunotherapy.
- To explore potential mechanisms by which the microbiome modulates anti-tumor immunity.
Main Methods:
- 16S rRNA gene sequencing and shotgun metagenomics were employed to profile the gut microbiome composition and function.
- Analysis of patient data correlating microbial profiles with clinical responses to immune checkpoint blockade therapy.
- In vivo and in vitro experiments to validate the immunomodulatory effects of specific bacterial strains.
Main Results:
- Distinct gut microbial signatures were associated with differential responses to immunotherapy.
- Enrichment of specific bacterial taxa, such as *Bacteroides* and *Akkermansia*, correlated with improved progression-free survival.
- Metabolic pathways related to short-chain fatty acid production were identified as potentially important mediators of immune response.
Conclusions:
- The gut microbiome plays a critical role in shaping the host immune environment and influencing the efficacy of cancer immunotherapy.
- Targeting the gut microbiota through interventions like fecal microbiota transplantation or probiotics may represent a promising strategy to enhance anti-tumor immunity and improve patient outcomes.
- Further research is warranted to elucidate the precise molecular mechanisms underlying these interactions and to develop personalized microbiome-based therapeutic strategies.